InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,699.94
(
-0.17%
)
US TECH 100
19,340.00
(
0.40%
)
Dow Jones
42,011.59
(
-0.44%
)
Brent Oil
78.59
(
1.00%
)
Bitcoin
61,308.66
(
0.92%
)
Post# of 403579
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Harry Wickey

Send PM Follow Ignore
Followers 17
Posts 677
Boards Moderated 0
Alias Born 12/30/2004

Harry Wickey

Re: Mrgreenfinger post# 350411

Thursday, 03/04/2021 7:26:34 PM

Thursday, March 04, 2021 7:26:34 PM

Post# of 403579
Innovation Pharmaceuticals Inc. is worth .28 cents a share not a penny more or penny less.
I believe this phase 2 trial (if successful) will lead to a phase 3 trial with a few thousand participants to see if Brilacidin is the real deal. Who will fund that study is anybody's guess. After success in phase 2, maybe $1.00 a share will happen but not much more without BP joining in.

For some reason people here think they will start putting Brilacidin in peoples veins if phase 2 shows efficacy. I don't think so.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM

Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM

Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM

Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM

Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM

Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM

Start posting your company's news
Only $200 per official company press release!